BioSpace News Archive

ECRI Institute, the nation’s leading independent, non-profit patient safety organization, opposes a total ban of commercial ethylene oxide (EtO) sterilization because it could result in widespread shortages of sterile medical devices.

Solera, the nation’s leading network of digital and community health partners, today announced the addition of four healthcare industry visionaries to the company’s advisory board

Technavio has been monitoring the global infectious disease therapeutics market and the market is poised to grow by USD 16.99 billion during 2019-2023, progressing at a CAGR of over 4% during the forecast period

Today, the National Coalition on Health Care (NCHC), an alliance of national health care provider, purchaser, labor, payer and consumer organizations, announced a new strategic partnership with Healthsperien, LLC, a leading Washington, D.C.-based health policy consulting firm.

Tizona Therapeutics, Inc., a clinical stage, privately held company developing first-in-class cancer immunotherapies, announced today the online publication of an article in Cancer Discovery describing novel mechanisms to more potently modulate the adenosine pathway and activate anti-tumor immune responses using antibodies that block CD39.

FDA revokes Indivior PLC’s orphan designation for opioid use disorder (OUD)* and prevents an additional five-year block of other monthly buprenorphine depot products for OUD

Company to host conference call on Monday, November 11, 2019 at 4:30pm EST to discuss current HBV landscape and update on the company’s development programs

Titan Pharmaceuticals, Inc. will announce its third quarter 2019 financial results after market close on Thursday, November 14, 2019. Following the release, Titan management will host a conference call at 4:30 p.m. EST / 1:30 p.m. PST to review the financial results and discuss business developments in the period.

22nd Century Builds Strong Momentum for its Very Low Nicotine Content Tobacco and Makes Significant Progress in the Development of Valuable New Hemp/Cannabis Plants

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the third quarter ended September 30, 2019.